ISRG reports $2.77B revenue and $2.50 EPS, beating forecasts as da Vinci procedures rise 16% year-over-year.
Intuitive Surgical (NASDAQ:ISRG) posted first-quarter revenue of $2.77 billion, surpassing the $2.62 billion estimate, driven by 16% year-over-year growth in da Vinci surgical procedures. Adjusted earnings per share reached $2.50, above the $2.1 consensus, as hospitals expanded robotic-assisted surgeries to clear backlogs and broaden treatment applications.
The company raised its full-year da Vinci procedure growth outlook to 13.5%-15.5%, up from prior guidance, despite a projected 1% tariff headwind. Gross margin targets were also lifted to 67.5%-68.5%, reflecting strong operational performance amid rising competition from Medtronic’s FDA-approved Hugo system.
Management’s bullish outlook underscores Intuitive Surgical’s dominance in robotic-assisted surgery, with analysts maintaining positive ratings despite a revised price target from Piper Sandler on April 22, 2026.